《Epilepsy & Behavior》重点专注发布医学-行为科学领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在医学-行为科学领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 5.4 | 0.867 | 0.901 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Neurology(clinical)
|
Q2 | 132/400 | 67% | |||
|
大类：大类：Medicine
小类：小类：BehavioralNeuroscience
|
Q2 | 30/88 | 66% | |||
|
大类：大类：Medicine
小类：小类：Neurology
|
Q2 | 66/192 | 65% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：BEHAVIORAL SCIENCES | SCIE | Q2 | 26 / 55 | 53.6% |
| 学科：CLINICAL NEUROLOGY | SCIE | Q3 | 146 / 277 | 47.5% |
| 学科：PSYCHIATRY | SCIE | Q2 | 131 / 276 | 52.7% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：BEHAVIORAL SCIENCES | SCIE | Q3 | 31 / 55 | 44.55% |
| 学科：CLINICAL NEUROLOGY | SCIE | Q2 | 128 / 278 | 54.14% |
| 学科：PSYCHIATRY | SCIE | Q2 | 125 / 276 | 54.89% |
文章名称
引用次数
Wearable technology in epilepsy: The views of patients, caregivers, and healthcare professionals
28
Open-label use of highly purified CBD (Epidiolex (R)) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
23
Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes
21
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
20
Automated seizure prediction
19
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
19
Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy
18
Putting it all together: Options for intractable epilepsy An updated algorithm on the use of epilepsy surgery and neurostimulation
16
Vagus nerve stimulation (VNS) therapy update
16
Laser interstitial thermal therapy (LITT): Seizure outcomes for refractory mesial temporal lobe epilepsy
16
国家/地区
发文量
TUSA
530
TEngland
169
TItaly
158
TGERMANY (FED REP GER)
112
TCanada
110
TCHINA MAINLAND
103
TTurkey
77
TAustralia
74
TFrance
73
TBrazil
69
